ANN ARBOR—A new study from the University of Michigan asserts that targets to reduce phosphorous outputs from the Detroit area to control toxic blooms of cyanobacteria in Lake Erie are unrealistic if the phosphorous inputs from Lake Huron aren’t controlled as well. In an effort to control the cyanobacteria blooms and dead zones that plague
ANN ARBOR—The Ann Arbor-based genetic research software developer Genomenon Inc. announced the release of version 2.0 of its Mastermind software. The genomic search engine now includes the ability to search the entirety of the genomic literature by phenotypes (symptoms). This new functionality will further accelerate diagnosis of patients with genetic and rare diseases. Patients, particularly those with
CANTON - TrialAssure – a software company focused on developing clinical trial transparency tools – has released Anonymize DS, the all-new software-as-a-service application that uses automation to anonymize sponsor’s clinical trial data. “As one of the first groups to automate the anonymization of datasets, our developers heard first-hand feedback from industry users during the limited
DETROIT—Henry Ford e-Home Care has announced a significant reduction in hospital readmissions for patients receiving telehealth care via Henry Ford’s e-Home Care program. Achieving monthly readmission rates as low as 7 percent, Henry Ford e-Home Care has reduced its average hospital readmission rate for the first six months of 2019 by 45 percent compared with
ROYAL OAK—OncoCell MDx Inc., a startup incubated at Harvard University to develop sophisticated cancer diagnosis from a simple blood sample, has raised $22.2 million in a Preferred Series B funding round. The financing was led by San Francisco-based Savitr Capital LLC, with participation from existing investors. OncoCell began operations in 2013, and since then has
ANN ARBOR - Genomenon, Inc., and Shanghai Shanyi Biological Technology Co., Ltd have formed a partnership to provide Genomenon’s leading Mastermind Genomic Search Engine to clinical laboratory customers in China. Genomenon’s Mastermind is a genomic search engine wiith nearly 3,500 users in over 100 countries, becoming the search engine of choice when researching patient variants
FARMINGTON HILLS—Ocuphire Pharma Inc., a clinical-stage pharmaceutical company developing therapies to treat patients with a variety of ophthalmic disorders, announced that it has closed on over $5 million of financing. Investors include Jackson-based RBI Opportunities Fund, Douglas, Mich.-based Belle Capital Fund, Grand Rapids-based Grand Angels Fund, Farmington Hills-based First Capital Fund, Ann Arbor-based Michigan Angel
ROYAL OAK — OncoCell MDx has hired Kirk Wojno, M.D., as its chief medical officer. OncoCell MDx is developing new, noninvasive molecular diagnostic assays. Wojno, a renowned urologic pathologist and expert in prostate biopsy interpretation, joins an expanding, experienced executive team. OncoCell MDx also recently announced the appointments of Mark McDonough as president and CEO
BOSTON - There is no doubt that 3D bioprinting is a technology of the future. Imagine being able to print a kidney or liver on demand. This is a stark contrast to the long wait for a donor organ today. Currently, the average wait time for a liver is 4 to 5 months and 2.5
ROCHESTER—OptimizeRx Corp. (Nasdaq: OPRX), the Rochester-based provider of digital communication services for pharmaceutical companies to patients and healthcare providers, has announced a proposed underwritten public offering of shares of its common stock. The company sold 1,538,500 shares of its common stock at a price of $13 per share. The proceeds of the offering, before deducting
